About Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik
During the past decade, Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik"
#1 collaborator was "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik
According to Clinical.Site data, the most researched conditions in "Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik" are
"Heart Failure" (3 trials), "Atrial Fibrillation" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials), "Heart Failure (HF)" (1 trials) and "Non-diabetic Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik" in a lesser frequency.
Clinical Trials Intervention Types at Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik
Most popular intervention types in "Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Finerenone (BAY94-8862)" (2 trials), "Neladenoson bialanate (BAY1067197)" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik
The vast majority of trials in "Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik" are
7 trials for "All" genders.
Clinical Trials Status at Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik
Currently, there are NaN active trials in "Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".